Augmento Enterprise and Genki

DeepTek is a Pune-based medical imaging AI company that aims to make quality radiology affordable and accessible. It serves more than 500 hospitals and imaging centers and supports government tuberculosis and public health screening programmes in India and the Asia-Pacific region.

Augmento Enterprise is a vendor-neutral radiology AI deployment platform with cloud PACS, structured smart reporting, explainable AI overlays, multi-center collaboration and analytics dashboards; it can run DeepTek, in-house and third-party AI models inside existing HIS, RIS and PACS workflows. Augmento X-Ray automates chest X-ray reporting, and Genki is a lung health screening tool for tuberculosis programmes, used with portable X-ray in community camps. Customers are public health agencies, hospitals and diagnostic chains.

• Vendor-neutral AI orchestration: runs DeepTek, in-house and third-party AI models in existing workflows.
• Cloud PACS and viewer: stores and displays studies with AI-based pathology prediction.
• Smart reporting: structured reports delivered by email or SMS.
• Explainable AI: bounding boxes, heatmaps and outlines support the reading radiologist.
• Analytics dashboard: tracks scans, radiologists, turnaround and pending studies.
• Genki TB screening: lung health screening tool for public health tuberculosis programmes.

Vietnam's tuberculosis programme and NGOs could use Genki with portable X-ray in community case finding campaigns. Hospital groups could use Augmento as a hub to run several imaging AI tools across branches. Diagnostic chains could combine cloud PACS and teleradiology to report studies from many sites centrally.

Lets hospitals run AI from several vendors on one platform instead of integrating each tool separately. Claims productivity gains of 10 to 20% for radiology teams, with over 100,000 multi-modality scans processed per month. Supports mass tuberculosis screening with portable X-ray and AI triage in low-resource settings. Holds approvals relevant to Southeast Asia, including Thai FDA and Indonesia's Ministry of Health.

Hospitals increasingly want a single platform to deploy and govern many imaging AI models rather than separate integrations for each. Tuberculosis remains a major burden in Vietnam, the Philippines and Indonesia, and WHO-endorsed computer-aided detection with portable X-ray is being scaled in active case finding programmes across the region.

DeepTek is based in Pune, India. Augmento is US FDA cleared and CE marked, and also approved by India's CDSCO, Thai FDA and Indonesia's Ministry of Health; its chest X-ray AI holds CE MDR Class IIb and a WHO recommendation for TB screening. It raised about US$10 million led by Tata Capital Healthcare Fund. Customers include Synapxe in Singapore and Vijaya Diagnostic Centre; Genki was deployed in Myanmar with UNOPS and in Kenya.